Open Access
Open access
volume 25 issue 4 pages 2360

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection

Publication typeJournal Article
Publication date2024-02-17
scimago Q1
wos Q1
SJR1.273
CiteScore9.0
Impact factor4.9
ISSN16616596, 14220067
PubMed ID:  38397037
Catalysis
Organic Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Abstract

This review explores the diverse applications of gold nanoparticles (AuNPs) in neurological diseases, with a specific focus on Alzheimer’s disease (AD), Parkinson’s disease (PD), and stroke. The introduction highlights the pivotal role of neuroinflammation in these disorders and introduces the unique properties of AuNPs. The review’s core examines the mechanisms by which AuNPs exert neuroprotection and anti-neuro-inflammatory effects, elucidating various pathways through which they manifest these properties. The potential therapeutic applications of AuNPs in AD are discussed, shedding light on promising avenues for therapy. This review also explores the prospects of utilizing AuNPs in PD interventions, presenting a hopeful outlook for future treatments. Additionally, the review delves into the potential of AuNPs in providing neuroprotection after strokes, emphasizing their significance in mitigating cerebrovascular accidents’ aftermath. Experimental findings from cellular and animal models are consolidated to provide a comprehensive overview of AuNPs’ effectiveness, offering insights into their impact at both the cellular and in vivo levels. This review enhances our understanding of AuNPs’ applications in neurological diseases and lays the groundwork for innovative therapeutic strategies in neurology.

Found 
Found 

Top-30

Journals

1
2
3
Pharmaceutics
3 publications, 5.45%
Nanotechnology in the Life Sciences
2 publications, 3.64%
Journal of Drug Delivery Science and Technology
2 publications, 3.64%
ACS Omega
2 publications, 3.64%
Molecules
1 publication, 1.82%
Gels
1 publication, 1.82%
Journal of Dementia and Alzheimer s Disease
1 publication, 1.82%
Medicina
1 publication, 1.82%
International Urology and Nephrology
1 publication, 1.82%
Beilstein Journal of Nanotechnology
1 publication, 1.82%
International Journal of Nanomedicine
1 publication, 1.82%
Antioxidants
1 publication, 1.82%
Frontiers in Pharmacology
1 publication, 1.82%
Progress in Molecular Biology and Translational Science
1 publication, 1.82%
Journal of Biological Research (Italy)
1 publication, 1.82%
Coordination Chemistry Reviews
1 publication, 1.82%
Journal of Alzheimer's Disease
1 publication, 1.82%
Neuroglia
1 publication, 1.82%
Advanced Therapeutics
1 publication, 1.82%
European Food Research and Technology
1 publication, 1.82%
CNS Neuroscience and Therapeutics
1 publication, 1.82%
International Journal of Molecular Sciences
1 publication, 1.82%
Advanced Technology in Neuroscience
1 publication, 1.82%
Nano Select
1 publication, 1.82%
Marine Drugs
1 publication, 1.82%
Molecular Pharmaceutics
1 publication, 1.82%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
1 publication, 1.82%
Topics in Catalysis
1 publication, 1.82%
3 Biotech
1 publication, 1.82%
Materials Advances
1 publication, 1.82%
1
2
3

Publishers

2
4
6
8
10
12
MDPI
12 publications, 21.82%
Springer Nature
12 publications, 21.82%
Elsevier
8 publications, 14.55%
Wiley
5 publications, 9.09%
Frontiers Media S.A.
3 publications, 5.45%
American Chemical Society (ACS)
3 publications, 5.45%
SAGE
2 publications, 3.64%
Royal Society of Chemistry (RSC)
2 publications, 3.64%
Beilstein-Institut
1 publication, 1.82%
Taylor & Francis
1 publication, 1.82%
PAGEPress Publications
1 publication, 1.82%
Medknow
1 publication, 1.82%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.82%
AIP Publishing
1 publication, 1.82%
Hindawi Limited
1 publication, 1.82%
Bentham Science Publishers Ltd.
1 publication, 1.82%
2
4
6
8
10
12
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
55
Share
Cite this
GOST |
Cite this
GOST Copy
Chiang M. et al. Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection // International Journal of Molecular Sciences. 2024. Vol. 25. No. 4. p. 2360.
GOST all authors (up to 50) Copy
Chiang M., Yang Yu. P., Nicol C. J., Wang C. Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection // International Journal of Molecular Sciences. 2024. Vol. 25. No. 4. p. 2360.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/ijms25042360
UR - https://doi.org/10.3390/ijms25042360
TI - Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection
T2 - International Journal of Molecular Sciences
AU - Chiang, Ming-Chang
AU - Yang, Yu Ping
AU - Nicol, Christopher J.B.
AU - Wang, Chieh-Ju
PY - 2024
DA - 2024/02/17
PB - MDPI
SP - 2360
IS - 4
VL - 25
PMID - 38397037
SN - 1661-6596
SN - 1422-0067
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Chiang,
author = {Ming-Chang Chiang and Yu Ping Yang and Christopher J.B. Nicol and Chieh-Ju Wang},
title = {Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
publisher = {MDPI},
month = {feb},
url = {https://doi.org/10.3390/ijms25042360},
number = {4},
pages = {2360},
doi = {10.3390/ijms25042360}
}
MLA
Cite this
MLA Copy
Chiang, Ming-Chang, et al. “Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection.” International Journal of Molecular Sciences, vol. 25, no. 4, Feb. 2024, p. 2360. https://doi.org/10.3390/ijms25042360.